<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04977739</url>
  </required_header>
  <id_info>
    <org_study_id>NFEC-2021-007</org_study_id>
    <nct_id>NCT04977739</nct_id>
  </id_info>
  <brief_title>Research on the Application and Mechanism of New Biological Probes in Biomedicine</brief_title>
  <official_title>Research on the Application and Mechanism of New Biological Probes in Biomedicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluorescence is one of the most commonly used research and detection techniques in the field&#xD;
      of biomedical science. The characteristics of fluorescent probe directly affect the&#xD;
      performance and application of fluorescence analysis and imaging. Aggregation-Caused&#xD;
      Quenching has limited the application of traditional fluorescent probes to some extent. This&#xD;
      project intends to systematically evaluate the detection efficiency of new methods through&#xD;
      the detection of biomarkers in clinical samples and the comparison with the detection methods&#xD;
      of traditional biomarkers, so as to provide theoretical and experimental basis for the&#xD;
      establishment of fast and simple biomarker detection technologies with new biological probes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>signal intensity of the probes</measure>
    <time_frame>one day</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Tumors</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Respiratory System Diseases</condition>
  <condition>Digestive System Diseases</condition>
  <condition>Endocrine System Diseases</condition>
  <condition>Metabolic Diseases</condition>
  <condition>Immune System Diseases</condition>
  <condition>Urinary System Diseases</condition>
  <condition>Nervous System Diseases</condition>
  <condition>Blood Diseases</condition>
  <condition>Infectious Diseases</condition>
  <arm_group>
    <arm_group_label>those with a condition</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>those without a condition</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>those with a condition</arm_group_label>
    <arm_group_label>those without a condition</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        NanFang Hospital samples&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Sign the informed consent form voluntarily.&#xD;
&#xD;
          -  Age 18-70 years old.&#xD;
&#xD;
          -  High expression (positive) group: The results of multiple laboratory tests indicate&#xD;
             that the marker is higher than the normal range.&#xD;
&#xD;
          -  Low expression (negative) healthy volunteer group: those with no underlying diseases&#xD;
             and no abnormalities in the physical examination.&#xD;
&#xD;
          -  Have routine examination to check the remaining body fluid samples, and the body fluid&#xD;
             samples are not contaminated.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Accompanied by other inflammations.&#xD;
&#xD;
          -  The data of the subject is not complete, or the collection of cases is incomplete due&#xD;
             to other reasons.&#xD;
&#xD;
          -  The researcher judged that it was not suitable to participate in this research.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bo Situ</last_name>
    <role>Study Director</role>
    <affiliation>Nanfang Hospital of Southern Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Situ</last_name>
    <phone>020-61641044</phone>
    <email>drstb@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nanfang Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Situ</last_name>
      <phone>020-61641044</phone>
      <email>drstb@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>August 15, 2021</last_update_submitted>
  <last_update_submitted_qc>August 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Urologic Diseases</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Endocrine System Diseases</mesh_term>
    <mesh_term>Immune System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

